Radiomics features on CT scans to predict response to HER2-targeted therapy of hepatic metastases from colorectal cancer.

Valentina Giannini,Simone Mazzetti,Arianna Defeudis,Giovanni Cappello,L. Vassallo,Angelo Vanzulli,Cristina De Mattia,Alberto Torresin,Salvatore Siena,Andrea Sartore-Bianchi,Francesco Leone,Cosimo Martino,Vittorina Zagonel,Silvia Marsoni,Daniele Regge

Radiomics features on CT scans to predict response to HER2-targeted therapy of hepatic metastases from colorectal cancer.

2019

Valentina Giannini
Simone Mazzetti
Arianna Defeudis
Giovanni Cappello
L. Vassallo
Angelo Vanzulli
Cristina De Mattia
Alberto Torresin
Salvatore Siena
Andrea Sartore-Bianchi
Francesco Leone
Cosimo Martino
Vittorina Zagonel
Silvia Marsoni
Daniele Regge

e15086Background: Metastatic Colorectal cancer (mCRC) is the 2nd cause of cancer death worldwide. Repeated cycles of therapies, combined with surgery in oligo-metastatic cases, are the therapeutic ...

Keywords:

Targeted therapy
Oncology
Colorectal cancer
Pathology
Internal medicine
Radiomics
Medicine
cancer death

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations